Anbiping Investor Relations Activity Record Form (February 24 to February 25, 2025)
Anbiping: 2024 Annual Results Report Announcement
2024 Annual Results Express Announcement
Prompt announcement on changes in shareholders\' equity
Simplified equity change report
An Biping: Announcement on Serious Abnormal Fluctuations in the Company\'s Stock Trading
An Biping: Response to the letter of inquiry regarding abnormal fluctuations in stock trading of Guangzhou Anbiping Pharmaceutical Technology Co., Ltd.
Reply to the letter of inquiry regarding abnormal fluctuations in stock trading of Guangzhou Anbiping Pharmaceutical Technology Co., Ltd.
Announcement of serious abnormal fluctuations in the company\'s stock trading
An Biping: Reply to the “Letter of Inquiry on Abnormal Fluctuations in Stock Trading of Guangzhou Anbiping Pharmaceutical Technology Co., Ltd.”
An Biping: Announcement on Abnormal Fluctuations in the Company\'s Stock Trading
Reply to the “Letter of Inquiry on Abnormal Fluctuations in Stock Trading of Guangzhou Anbiping Pharmaceutical Technology Co., Ltd.”
Notice of abnormal fluctuations in the company\'s stock trading
Anbiping Investor Relations Activity Record Form (February 12 to February 14, 2025)
Anbiping Investor Relations Activity Record Form (February 10, 2025)
Anbiping Investor Relations Activity Record List (January 16, 2025)
An Biping: Announcement on voluntary disclosure of the qualifications obtained by the company and its subsidiaries from October to December 2024
Announcement on voluntary disclosure of the qualifications obtained by the company and its subsidiaries from October to December 2024
Notice on voluntary disclosure of HER2 genetic test kits (fluorescence in situ hybridization) to obtain approval for medical device registration changes
Anbiping Investor Relations Activity Record Form (December 27, 2024)